About
Kelly Velasco joined the Halberg lab in 2021. She is a cell and molecular biologist interested in deciphering the function of proteins that have an impact for human health but have not been yet fully characterised. She has participated in studies across a variety of topics (the malaria parasite (Plasmodium spp.), the ubiquitin system and the regulation of insulin secretion) and has therefore experience with different cellular models as well as useful techniques for the study of protein function. Currently, she is part of our hit-to-lead program to develop a novel targeted therapy against Triple-Negative Breast Cancer.